Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Children's Oncology Group
Children's Oncology Group
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Angers
Masonic Cancer Center, University of Minnesota
Goethe University
National Cancer Institute (NCI)
Nanfang Hospital, Southern Medical University
Nanfang Hospital, Southern Medical University
National Cancer Institute (NCI)